Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Biotech-beach crawled time : 22:00 save search
Blacksmith Medicines To Highlight Preclinical Oncology Data Demonstrating a Potent and Selective FEN1 Inhibitor Has Synergy with Multiple DDR Drug Classes at AACR Annual Meeting 2024
Published: 2024-04-10 (Crawled : 22:00) - biospace.com/
LLY | News | $742.04 1.46% 540K
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
drug preclinical meeting
Dermata Therapeutics Provides Corporate Update and Reports Full Year 2023 Financial Results
Published: 2024-03-21 (Crawled : 22:00) - biospace.com/
DRMA | $0.3514 12K
|
|
| O: 2.5%
H: 7.95%
C: -2.44%
year update therapeutics financial results
Ligand Pharmaceuticals to Present at Barclays 26th Annual Global Healthcare Conference
Published: 2024-03-05 (Crawled : 22:00) - biospace.com/
LGND | $70.53 2.92% 24K
|
Health Technology
|
| O: -0.75%
H: 1.55%
C: -2.26%
conference pharmaceuticals global
Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - February 1, 2024
Published: 2024-02-01 (Crawled : 22:00) - biospace.com/
ONCT | $8.55 690
|
Health Technology
|
| O: -2.66%
H: 6.01%
C: -0.53%
award nasdaq therapeutics
Study Shows that OGM Plays an Important Role in Efficient Diagnosis of FSHD
Published: 2023-11-30 (Crawled : 22:00) - biospace.com/
BNGO | $0.7702 1.26% 540K
|
Health Technology
|
| O: 2.53%
H: 9.88%
C: -1.85%
study
ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update
Published: 2023-11-08 (Crawled : 22:00) - biospace.com/
THMO | $0.65 2.1K
|
Health Technology
|
| O: -0.73%
H: 4.53%
C: 2.16%
update financial results
Artiva Biotherapeutics Receives Immunology Innovation of the Year in the 2023 BioTech Breakthrough Awards Program
Published: 2023-11-08 (Crawled : 22:00) - biospace.com/
AFMD | $5.22 4.4% 4.8K
|
Health Technology
|
| O: -2.38%
H: 6.05%
C: 1.45%
biotech year innovation awards immunology program
Simulations Plus Reports Fourth Quarter and Fiscal 2023 Financial Results
Published: 2023-10-25 (Crawled : 22:00) - biospace.com/
SLP | $45.79 1.76% 28K
|
Technology Services
|
| O: -1.0%
H: 0.66%
C: -0.79%
plus financial results
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 14, 2023
Published: 2023-10-25 (Crawled : 22:00) - biospace.com/
ARCT 4 | $28.22 4.29% 110K
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: -4.25%
report update therapeutics financial results
Arrowhead Pharmaceuticals to Participate in Upcoming September 2023 Conferences
Published: 2023-09-01 (Crawled : 22:00) - biospace.com/
MS | News 0 d | $93.2 1.21% 1.1M
|
Finance
|
| O: 0.46%
H: 0.0%
C: 0.0%
ARWR | $24.33 1.71% 310K
|
Health Technology
|
| O: 0.51%
H: 2.23%
C: 0.65%
pharmaceuticals
Tandem Diabetes Care Announces Second Quarter 2023 Financial Results and Updated Full Year 2023 Financial Guidance
Published: 2023-08-03 (Crawled : 22:00) - biospace.com/
TNDM | $33.72 6.27% 1.2M
|
Health Technology
|
| O: -0.92%
H: 1.52%
C: -0.65%
year care diabetes financial results
Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2023 Financial Results
Published: 2023-08-03 (Crawled : 22:00) - biospace.com/
LBPH | $20.59 10.28% 170K
|
Manufacturing
|
| O: 0.98%
H: 5.68%
C: 3.74%
update pharmaceuticals financial results
Ventyx Biosciences to Report Second Quarter 2023 Financial Results on August 10, 2023
Published: 2023-08-03 (Crawled : 22:00) - biospace.com/
VTYX | $4.37 1.63% 150K
|
Manufacturing
|
| O: -0.44%
H: 0.0%
C: -2.6%
report financial results
Travere Therapeutics Reports Second Quarter 2023 Financial Results
Published: 2023-08-03 (Crawled : 22:00) - biospace.com/
TVTX | $5.89 0.68% 460K
|
Health Technology
|
| O: -0.48%
H: 1.51%
C: -1.57%
therapeutics financial results
Arrowhead Pharmaceuticals to Webcast Fiscal 2023 Third Quarter Results
Published: 2023-07-24 (Crawled : 22:00) - biospace.com/
ARWR | $24.33 1.71% 310K
|
Health Technology
|
| O: -0.25%
H: 1.22%
C: -2.58%
pharmaceuticals results
Neurocrine Biosciences Presents INGREZZA® (valbenazine) Capsules Data on Tardive Dyskinesia Improvement Regardless of Baseline Antipsychotic Use at 2023 Psych Congress Elevate
Published: 2023-06-02 (Crawled : 22:00) - biospace.com/
NBIX | News M | $140.41 5.05% 620K
|
Health Technology
|
| O: -0.21%
H: 1.68%
C: 1.45%
ingrezza
Mirati Therapeutics to Participate at the Goldman Sachs 44th Annual Global Healthcare Conference 2023
Published: 2023-06-01 (Crawled : 22:00) - biospace.com/
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: -0.89%
H: 1.36%
C: 0.49%
conference global therapeutics
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2023
Published: 2023-05-03 (Crawled : 22:00) - biospace.com/
AMPH | $41.055 2.2% 80K
|
Health Technology
|
| O: 0.51%
H: 1.59%
C: -2.4%
conference pharmaceuticals
Arcutis Announces Canadian Approval of ZORYVE™ (roflumilast) Cream 0.3% for Treatment of Plaque Psoriasis in Individuals 12 Years and Older
Published: 2023-04-28 (Crawled : 22:00) - biospace.com/
ARQT | $8.965 0.28% 680K
|
Health Technology
|
| O: 0.07%
H: 2.9%
C: 0.51%
approval psoriasis treatment
Mirati Therapeutics to Participate at the Bank of America Securities 2023 Health Care Conference
Published: 2023-04-27 (Crawled : 22:00) - biospace.com/
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: 1.44%
H: 0.66%
C: -0.21%
america conference health care therapeutics
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.595 164.08% 13M
|
AGBA | $2.61 108.8% 41M
|
Finance
CZOO | $9.32 86.77% 18M
|
EDBL | News | $6.7 78.19% 1.7M
|
MTC | $2.28 46.15% 2.6M
|
Technology Services
OPRT | News | $3.14 39.56% 7.6M
|
Finance
VNRX | $0.8 33.33% 2.9M
|
Health Technology
MLEC | $1.865 33.21% 2.4M
|
n/a
PALI | $6.37 29.21% 21M
|
Manufacturing
LOCL | $3.33 27.59% 43K
|
Your saved searches
Save your searches and get alerts when important news are released.